About Aqueduct Neurosciences
Aqueduct Neurosciences is a company based in Seattle (United States) founded in 2010. It operates as a B2B. Aqueduct Neurosciences has raised $6.78 million across 4 funding rounds from investors including HHS and Keiretsu Capital. Aqueduct Neurosciences operates in a competitive market with competitors including CereVasc, IRRAS, Longeviti, Aqueduct Critical Care and Tissuemed, among others.
- Headquarter Seattle, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.78 M (USD)
in 4 rounds
-
Latest Funding Round
$2.01 M (USD), Debt – Convertible
Dec 21, 2016
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Aqueduct Neurosciences
Aqueduct Neurosciences has successfully raised a total of $6.78M across 4 strategic funding rounds. The most recent funding activity was a Debt – Convertible round of $2.01 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Debt – Convertible — $2.0M
-
First Round
First Round
(30 Aug 2011)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2016 | Amount | Debt – Convertible - Aqueduct Neurosciences | Valuation |
investors |
|
| May, 2016 | Amount | Series A - Aqueduct Neurosciences | Valuation |
investors |
|
| Sep, 2011 | Amount | Grant - Aqueduct Neurosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aqueduct Neurosciences
Aqueduct Neurosciences has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and Keiretsu Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed by Keiretsu Capital into multiple sectors.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aqueduct Neurosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aqueduct Neurosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aqueduct Neurosciences Comparisons
Competitors of Aqueduct Neurosciences
Aqueduct Neurosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CereVasc, IRRAS, Longeviti, Aqueduct Critical Care and Tissuemed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
eShunt device is developed for communicating hydrocephalus treatment.
|
|
| domain | founded_year | HQ Location |
Provider of devices for fluid control and management after surgery
|
|
| domain | founded_year | HQ Location |
Implantable neurosurgical devices are developed for cranial defect correction.
|
|
| domain | founded_year | HQ Location |
Novel products to manage Cerebral Spinal Fluid (CSF) pressure
|
|
| domain | founded_year | HQ Location |
Bioadhesive films are developed to seal leaks in surgical procedures.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Aqueduct Neurosciences
When was Aqueduct Neurosciences founded?
Aqueduct Neurosciences was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Where is Aqueduct Neurosciences located?
Aqueduct Neurosciences is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Is Aqueduct Neurosciences a funded company?
Aqueduct Neurosciences is a funded company, having raised a total of $6.78M across 4 funding rounds to date. The company's 1st funding round was a Grant of $350K, raised on Aug 30, 2011.
What does Aqueduct Neurosciences do?
Aqueduct Neurosciences, backed by 9139481.0 from Keiretsu Capital, HHS, focuses on providing healthcare solutions, developing medical devices, neurology, and implantable devices. Develops implantable shunts to treat hydrocephalus. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of Aqueduct Neurosciences?
Aqueduct Neurosciences's top competitors include CereVasc, Tissuemed and Aqueduct Critical Care.
Who are Aqueduct Neurosciences's investors?
Aqueduct Neurosciences has 2 investors. Key investors include HHS, and Keiretsu Capital.